DIVIS LABORATORIES
|
The Current P/S Ratio of DIVIS LABORATORIES is 18.87.
Share Price | ₹6,652.6 | Jul 30,2025 |
Market Cap | ₹176,625.2 Cr | |
Sales-TTM | ₹9,360.0 Cr | TTM-Consolidated Results |
Price/Sales | 18.87x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹176,625.2 Cr] as on Jul 30,2025
(/) Sales [ ₹9,360.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 18.87x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '18.87 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES
PS Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.89x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 13.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 16.34x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.
How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
DIVIS LABORATORIES | 9,360.0 | 18.87 | 176,625.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.92 | 416,273.0 |
CIPLA LTD | 27,811.2 | 4.53 | 125,993.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.67 | 126,316.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.22 | 107,795.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.66 | 106,278.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.31 | 100,125.0 |
LUPIN LTD | 22,707.9 | 3.99 | 90,623.2 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.12 | 67,198.8 |
ABBOTT INDIA LTD | 6,409.2 | 11.67 | 74,773.9 |
ALKEM LABORATORIES LTD | 12,964.5 | 4.70 | 60,959.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.12x |
Max industry PS | 18.87x |
Median industry PS | 4.70x |
Average industry PS | 7.33x |
You may also like the below Video Courses